|
|
circulatory system process
|
GO:0003013 |
197 |
0.661
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.579
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.486
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.480
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.472
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.432
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.401
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.384
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.383
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.373
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.363
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.332
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.321
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.312
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.309
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.305
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.292
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.284
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.278
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.265
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.256
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.252
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.251
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.244
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.243
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.239
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.237
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.222
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.220
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.217
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.207
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.201
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.199
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.198
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.189
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.185
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.182
|
|
|
|
vascular endothelial growth factor production
|
GO:0010573 |
13 |
0.182
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.179
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.174
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.172
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.172
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.166
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.165
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.165
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.161
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.161
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.159
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.158
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.155
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.154
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.153
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.152
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.147
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.144
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.144
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.143
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.143
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.140
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.140
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.137
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.135
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.135
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.134
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.133
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.133
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.133
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.133
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.130
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.130
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.130
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.129
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.128
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.127
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.124
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.118
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.118
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.114
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.114
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.113
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.112
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.107
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.107
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.106
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.106
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.104
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.104
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.103
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.103
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.102
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.102
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.102
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.101
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.101
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.100
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.098
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.096
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.096
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.096
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.095
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.095
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.094
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.094
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.094
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.094
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.093
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.093
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.092
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.090
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.090
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.090
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.090
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.090
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.089
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.088
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.088
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.085
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.083
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.083
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.082
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.082
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.081
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.081
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.081
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.081
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.081
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.080
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.080
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.079
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.079
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.079
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.079
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.077
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.077
|
|
|
|
leukocyte degranulation
|
GO:0043299 |
27 |
0.077
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.077
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.077
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.077
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.077
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.076
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.076
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.075
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.075
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.075
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.075
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.075
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.074
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.073
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.072
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.072
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.072
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.072
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.072
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.072
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.071
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.071
|
Rat |
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.070
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.069
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.069
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.069
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.069
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.069
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.068
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.068
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.068
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.067
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.067
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.065
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.065
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.065
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.064
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.064
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.064
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.063
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.063
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.063
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.062
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.062
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.062
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.062
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.062
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.061
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.061
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.061
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.061
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.061
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.060
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.060
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.060
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.060
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.060
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.059
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.059
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.059
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.059
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.058
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.058
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.058
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.058
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.058
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.057
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.057
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.057
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.057
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.057
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.057
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.057
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.057
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.057
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.057
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.057
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.057
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.056
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.056
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.056
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.056
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.056
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.055
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.055
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.054
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.054
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.054
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.053
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.053
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.053
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.053
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.053
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.052
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.052
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.052
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.052
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.051
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.051
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.050
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.050
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.050
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.050
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.050
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.050
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.049
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.049
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.049
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.049
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.049
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.049
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.048
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.048
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.048
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.048
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.048
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.047
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.047
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.047
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.047
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.046
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.046
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.046
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.046
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.046
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.046
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.046
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.046
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.046
|
|
|
|
regulation of mast cell activation
|
GO:0033003 |
21 |
0.045
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.045
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.045
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.045
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.045
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.045
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.044
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.044
|
|
|
|
regulation of vascular endothelial growth factor production
|
GO:0010574 |
13 |
0.044
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.044
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.044
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.044
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.044
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.044
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.044
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.044
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.044
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.043
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.043
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.043
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.043
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.043
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.043
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.043
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.043
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.043
|
|
|
|
positive regulation of lipoprotein lipase activity
|
GO:0051006 |
3 |
0.043
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.042
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.042
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.042
|
|
|
|
t cell extravasation
|
GO:0072683 |
4 |
0.042
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.042
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.042
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.042
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.042
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.042
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.041
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.041
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.041
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.041
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.041
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.041
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.041
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.041
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.041
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.040
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.040
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.040
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.040
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.040
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.040
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.040
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.040
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.040
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.040
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.040
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.039
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.039
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.039
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.039
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.039
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.039
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.039
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.039
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.039
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.039
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.039
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.039
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.038
|
|
|
|
positive regulation vascular endothelial growth factor production
|
GO:0010575 |
10 |
0.038
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.038
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.038
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.038
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.038
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.038
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.038
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.038
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.038
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.037
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.037
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.037
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.037
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.037
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.037
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.037
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.037
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.037
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.037
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.037
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.036
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.036
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.036
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.036
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.036
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.036
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.036
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.035
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.035
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.035
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.035
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.035
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.035
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.035
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.035
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.035
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.035
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.034
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.034
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.034
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.034
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.034
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.034
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.034
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.034
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.034
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.034
|
|
|
|
wound healing involved in inflammatory response
|
GO:0002246 |
4 |
0.034
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.033
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.033
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.033
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.033
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.033
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.033
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.033
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.032
|
|
|
|
regulation of regulated secretory pathway
|
GO:1903305 |
20 |
0.032
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.032
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.032
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
23 |
0.032
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.032
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.032
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.032
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.032
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.032
|
|
|
|
mast cell activation
|
GO:0045576 |
27 |
0.032
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.032
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.032
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.032
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.031
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.031
|
|
|
|
regulation of myeloid leukocyte mediated immunity
|
GO:0002886 |
25 |
0.031
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.031
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.031
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.031
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.031
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.031
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.031
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.031
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.031
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.031
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.031
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.031
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.030
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.030
|
|
|
|
metanephric glomerulus vasculature morphogenesis
|
GO:0072276 |
3 |
0.030
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.030
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.030
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.030
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.030
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.030
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.030
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.030
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.030
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.030
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.029
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.029
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.029
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.029
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.029
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.029
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.029
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.029
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.029
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.029
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.029
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.029
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.029
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.029
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.029
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.029
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.029
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.029
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.029
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.029
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.029
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.029
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.029
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.029
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.028
|
Rat |
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.028
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.028
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.028
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.028
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.028
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.028
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.028
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.028
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.028
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.028
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.028
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.028
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.028
|
|
|
|
inflammatory response to wounding
|
GO:0090594 |
4 |
0.028
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
6 |
0.028
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.028
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.027
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.027
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.027
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.027
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.027
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.027
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.027
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.027
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.027
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.027
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.027
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.027
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.027
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.027
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.027
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.027
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.027
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.026
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.026
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.026
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.026
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.026
|
|
|
|
benzene containing compound metabolic process
|
GO:0042537 |
5 |
0.026
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.026
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.026
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.026
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.026
|
|
